Live feed19:00:00·1277dPRReleasevia QuantisnowAgios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and ExpositionByQuantisnow·Wall Street's wire, on your screen.AGIO· Agios Pharmaceuticals Inc.Health Care
